The controversial antiviral drug Remdesevir got a boost today after Dr Anthony Fauci, the most trusted voice in the US when speaking of Covid-19, announced the drug has has a “clear-cut” effect in helping Covid-19 patients recover.
“The data show that Remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery, proving that a drug can block this virus.”
His remarks at the White House echo those of a top US scientist who oversaw the largest clinical trial to date into the highly-anticipated medicine. Fauci likened the finding to the first retrovirals that worked, albeit with modest success, against HIV in the 1980s.
The drug’s maker, Gilead Sciences, said yesterday it had met its primary goals in the largest and most robust investigation to date.
The National Institute of Allergy and Infectious Diseases, led by Fauci, hasn’t yet released a detailed summary of the results, so it remains difficult to quantify exactly how well the drug performed.
Still, it represents the first time any medication has been conclusively shown to improve outcomes against Covid-19 , which has claimed more than 228,000 lives globally and brought the world’s economies to a grinding halt.
There has been mixed news about the intravenous antiviral in recent weeks. A summary of results posted on the website of the World Health Organization last week showed it failed in a smaller Chinese trial. That trial, however, was terminated due to lackof enrollment, and is considered statistically insignificant.
In a study of 237 patients in Wuhan, China, doctors found no positive effects of administering the drug compared with a control group of adults, except among those patients who required ventilators.
But the Chinese test had to be halted early because it could not recruit enough people to meet its initial goals, and was considered by many experts to be too small to draw reliable conclusions from.
Fauci said it was “not an adequate study.”
The US-led trial, however, which began in late February, is the largest yet to investigate Remdesivir and is technically the most robust.
A data sheet showed its estimated enrollment at 800 patients, a portion of whom received the actual drug while the rest got a placebo. The trial was conducted at multiple sites around the world. Neither the patients nor their doctors knew which group they belonged to, in order to eliminate unconscious bias.
The main goal of the study was to evaluate how long patients take to recover with versus without the drug, with 3 different categories of recovery:
- Hospitalised but no longer needing oxygen;
- Discharged from hospital but still limited in home activities;
- Discharged from hospital with no limits on home activities.
Without numeric data it is hard to judge just how well patients did but Gilead’s statement indicates there was a significant improvement, about 30%, over the placebo.
It was a Phase 3 trial, the final stage before any medication can receive regulatory approval from the Food and Drug Administration (FDA).
Remdesivir, which was originally developed to combat Ebola but never approved, belongs to a class of drugs that act on the virus directly, as opposed to controlling the abnormal and often lethal autoimmune response it causes.
It mimics one of the four building blocks of RNA and DNA and is absorbed into the virus’s genome, which in turn stops it from replicating.
Antimalarial drugs chloroquine and hydroxychloroquine are also being used widely against Covid-19 on a so-called “compassionate basis,” meaning only in severe cases, pending results from large trials, with early studies decidedly mixed.
Other therapies that are being studied include collecting antibodies from Covid-19 survivors and injecting patients with them, or harvesting antibodies from genetically-engineered mice that were deliberately infected.
Get more from The Thaiger
Join the conversation and have your say on Thailand news published on The Thaiger.
Thaiger Talk is our new Thaiger Community where you can join the discussion on everything happening in Thailand right now.
Please note that articles are not posted to the forum instantly and can take up to 20 min before being visible. Click for more information and the Thaiger Talk Guidelines.
Mother seeks justice after a monk slapped her son
Bangkok ranked one of top 5 expat cities
Woman abandons home after police ignore four burglaries
VIDEO: Brave citizens save delivery driver swept away by floods in northeast Thailand
Chiang Mai wakes up to a flooded city district
Japanese warned to take cover over North Korea missile test
Book on Trump reveals casual racism and homophobia
Thai bank releases bizarre ‘apology’ for repossessing the wrong house
Thailand wants more tourists from Kazakhstan and Uzbekistan
Elon Musk angers Ukraine president with Russia tweets
Europeans arrested in Iran
Thai woman charged for selling fake discount vouchers
Expressway killer reveals 3 month plan to murder girlfriend in remorseless confession
Prayut plans to contact citizens hit by power cuts via radio
Submarine purchases could sink over engine debate
5 suit tailors in Bangkok that’ll make you look dapper
Things to do in Bangkok that cost next to nothing (2022)
VIDEO: 500 year old Buddhist stupa collapses in Chiang Mai revealing hidden treasures
Thailand’s strange laws – 10 strange laws in Thailand
Is the dream over? China walks back Belt & Road ambitions
OnlyFans star sentenced to six years in prison in Myanmar
Thailand’s weak baht could have a silver lining in the tourism industry, THA says
Woman’s body in luggage found floating in Mekong River
Thai baht plunges to 38 against US dollar for first time in 16 years
Canadian gangster in Phuket killing faces death penalty in Thailand
Snitching on parking space hoggers could earn you 5,000 baht in Thailand
20 baht notes printed with errors, says Bank of Thailand
Maya Bay reopens once again to the public
Thai lotto winners reward ghosts with pricey Japanese feast
Thailand to extend Smart Visa scheme to draw talent
Morning Top Stories Thailand | Police to end protests, Human Trafficking | September 14
Thailand News Today | Thai Airways in rehab, All go for Songkran | March 4
Phuket’s nightlife. Yes, bars and clubs are still open | VIDEO
Thailand News Today | Covid passport talks, Thai Airways heads to court | March 2
Phuket Thai food treats you need to try | VIDEO
Thailand News Today | Bars, pubs and restaurants ‘sort of’ back to normal | Feb 23
In search of Cat & Dog Cafés in Phuket Town | VIDEO
Thailand News Today | Gambling crackdown, Seafood market to reopen, Vlogger challenge | Jan 21
Thailand News Today | Covid testing for visas, Business impact, Vaccine approval | January 19
Thailand News Today | Weekend Bangkok bombs, Thailand fires, Covid update | January 18
Thailand News Today | Stray car on runway, Indonesian quake, 300 baht tourist fee | January 15
Thailand News Today | Governor off respirator, sex-trafficking arrest, condo prices falling | January 14
Thailand News Today | Chinese vaccine, Thailand ‘drug hub’, Covid update | January 13
Thailand News Today | Bangkok may ease restrictions, Phuket bar curfew, Vaccine roll out | January 12
Thailand News Today | Covid latest, Cockfights closed down, Bryde’s Whale beached | January 11
Environment1 day ago
Maya Bay reopens once again to the public
Thailand1 day ago
Thailand’s cold season expected to hit in late October
Bangkok3 days ago
Anti-Prayut rallies expected across Bangkok
Chiang Mai24 hours ago
River in Chiang Mai overflows, floods spread
Bangkok3 days ago
Garbage in canals worsens flooding in Bangkok
Property4 days ago
What $100,000 buys you for a condo in Bangkok, Phuket, Pattaya, Koh Samui and Hua Hin
North East1 day ago
30 trail runners stuck in Isaan forest due to flash flood
Thailand1 day ago
Bank repossesses the wrong house in central Thailand